Abstract
Neuropilin-1 (NRP1) functions as a coreceptor through interaction with plexin A1 or vascular endothelial growth factor (VEGF) receptor during neuronal development and angiogenesis. NRP1 potentiates the signaling pathways stimulated by semaphorin 3A and VEGF-A in neuronal and endothelial cells, respectively. In this study, we investigate the role of tumor cell-expressed NRP1 in glioma progression. Analyses of human glioma specimens (WHO grade I–IV tumors) revealed a significant correlation of NRP1 expression with glioma progression. In tumor xenografts, overexpression of NRP1 by U87MG gliomas strongly promoted tumor growth and angiogenesis. Overexpression of NRP1 by U87MG cells stimulated cell survival through the enhancement of autocrine hepatocyte growth factor/scatter factor (HGF/SF)/c-Met signaling. NRP1 not only potentiated the activity of endogenous HGF/SF on glioma cell survival but also enhanced HGF/SF-promoted cell proliferation. Inhibition of HGF/SF, c-Met and NRP1 abrogated NRP1-potentiated autocrine HGF/SF stimulation. Furthermore, increased phosphorylation of c-Met correlated with glioma progression in human glioma biopsies in which NRP1 is upregulated and in U87MG NRP1-overexpressing tumors. Together, these data suggest that tumor cell-expressed NRP1 promotes glioma progression through potentiating the activity of the HGF/SF autocrine c-Met signaling pathway, in addition to enhancing angiogenesis, suggesting a novel mechanism of NRP1 in promoting human glioma progression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Abounader R, Lal B, Luddy C, Koe G, Davidson B, Rosen EM et al. (2002). In vivo targeting of SF/HGF and c-met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosis. FASEB J 16: 108–110.
Abounader R, Laterra J . (2005). Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis. Neuro-oncol 7: 436–451.
Akagi M, Kawaguchi M, Liu W, McCarty MF, Takeda A, Fan F et al. (2003). Induction of neuropilin-1 and vascular endothelial growth factor by epidermal growth factor in human gastric cancer cells. Br J Cancer 88: 796–802.
Bachelder RE, Lipscomb EA, Lin X, Wendt MA, Chadborn NH, Eickholt BJ et al. (2003). Competing autocrine pathways involving alternative neuropilin-1 ligands regulate chemotaxis of carcinoma cells. Cancer Res 63: 5230–5233.
Bagri A, Tessier-Lavigne M . (2002). Neuropilins as Semaphorin receptors: in vivo functions in neuronal cell migration and axon guidance. Adv Exp Med Biol 515: 13–31.
Ding H, Wu X, Roncari L, Lau N, Shannon P, Nagy A et al. (2000). Expression and regulation of neuropilin-1 in human astrocytomas. Int J Cancer 88: 584–592.
Gagnon ML, Bielenberg DR, Gechtman Z, Miao HQ, Takashima S, Soker S et al. (2000). Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor: in vivo expression and antitumor activity. Proc Natl Acad Sci USA 97: 2573–2578.
Gao CF, Vande Woude GF . (2005). HGF/SF-Met signaling in tumor progression. Cell Res 15: 49–51.
Guo P, Xu L, Pan S, Brekken RA, Yang ST, Whitaker GB et al. (2001). Vascular endothelial growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sites. Cancer Res 61: 8569–8577.
Hu B, Guo P, Fang Q, Tao HQ, Wang D, Nagane M et al. (2003). Angiopoietin-2 induces human glioma invasion through the activation of matrix metalloprotease-2. Proc Natl Acad Sci USA 100: 8904–8909.
Klagsbrun M, Takashima S, Mamluk R . (2002). The role of neuropilin in vascular and tumor biology. Adv Exp Med Biol 515: 33–48.
Laterra J, Rosen E, Nam M, Ranganathan S, Fielding K, Johnston P . (1997). Scatter factor/hepatocyte growth factor expression enhances human glioblastoma tumorigenicity and growth. Biochem Biophys Res Commun 235: 743–747.
Miao HQ, Lee P, Lin H, Soker S, Klagsbrun M . (2000). Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression. FASEB J 14: 2532–2539.
Parikh AA, Fan F, Liu WB, Ahmad SA, Stoeltzing O, Reinmuth N et al. (2004). Neuropilin-1 in human colon cancer: expression, regulation, and role in induction of angiogenesis. Am J Pathol 164: 2139–2151.
Rieger J, Wick W, Weller M . (2003). Human malignant glioma cells express semaphorins and their receptors, neuropilins and plexins. Glia 42: 379–389.
West DC, Rees CG, Duchesne L, Patey SJ, Terry CJ, Turnbull JE et al. (2005). Interactions of multiple heparin binding growth factors with neuropilin-1 and potentiation of the activity of fibroblast growth factor-2. J Biol Chem 280: 13457–13464.
Wey JS, Gray MJ, Fan F, Belcheva A, McCarty MF, Stoeltzing O et al. (2005). Overexpression of neuropilin-1 promotes constitutive MAPK signalling and chemoresistance in pancreatic cancer cells. Br J Cancer 93: 233–241.
Acknowledgements
The work was supported by grants NIH CA102011 and RSG CSM-107144 (S-Y C), the Hillman Fellows Program for Innovative Cancer Research to S-Y C and B H, and grant NIH CA095809 to TM (in part).
Author information
Authors and Affiliations
Corresponding authors
Additional information
Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc).
Supplementary information
Rights and permissions
About this article
Cite this article
Hu, B., Guo, P., Bar-Joseph, I. et al. Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway. Oncogene 26, 5577–5586 (2007). https://doi.org/10.1038/sj.onc.1210348
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1210348
Keywords
This article is cited by
-
Neuropilin-1 is over-expressed in claudin-low breast cancer and promotes tumor progression through acquisition of stem cell characteristics and RAS/MAPK pathway activation
Breast Cancer Research (2022)
-
Role of Neuropilin-2-mediated signaling axis in cancer progression and therapy resistance
Cancer and Metastasis Reviews (2022)
-
Perspectives and potential approaches for targeting neuropilin 1 in SARS-CoV-2 infection
Molecular Medicine (2021)
-
Soluble Neuropilin-1 is an independent marker of poor prognosis in early breast cancer
Journal of Cancer Research and Clinical Oncology (2021)
-
MiR-200c sensitizes Olaparib-resistant ovarian cancer cells by targeting Neuropilin 1
Journal of Experimental & Clinical Cancer Research (2020)